Cytarabine renal toxicity
WebApr 26, 2024 · Fertility studies to assess the reproductive toxicity of cytarabine have not been conducted. Gonadal suppression, resulting in amenorrhea or azoospermia, may occur in patients taking cytarabine therapy, especially in combination with alkylating agents. ... Renal and urinary disorders . Common: Renal impairment, urinary retention . Not known ... WebDec 4, 2024 · Prolonged, often severe, myelosuppression (typically ANC <500 cells per μL or platelets <10 000 to 20 000/μL) associated with venetoclax and HMA/low-dose …
Cytarabine renal toxicity
Did you know?
WebMost studies using high-dose cytarabine (ara-c) for the therapy of acute leukemia have employed intermittent short infusions. In this study, we have evaluated the pharmacology and toxicity of high-dose ara-c by 72-hour continuous infusion. Plasma ara-c concentrations varied from 3.6 μM at the starting dose of 4 g/m 2 /72 hours to 22.6 μM at ... Webpatients with renal or hepatic function impairment may have a higher likelihood of CNS toxicity after high-dose cytarabine treatment. Use the drug with caution and possibly at …
Websufficient to monitor drug tolerance and protect and maintain a patient compromised by drug toxicity. The main toxic effect of cytarabine injection is bone marrow suppression with … WebDec 22, 2010 · Abstract. The occurrence of pulmonary infiltrates in leukemic patients undergoing chemotherapy may be attributed to either infectious or noninfectious causes. Cytarabine-induced toxicity, probably related to a cytokine-mediated mechanism, is an under-recognized etiology of respiratory symptoms and lung infiltrates, so that an early …
WebAug 12, 2024 · Cytarabine is a pyrimidine analog and is also known as arabinosylcytosine (ARA-C). It is converted into the triphosphate form within the cell and competes with cytidine to incorporate itself into the DNA. The sugar moiety of cytarabine hinders the rotation of the molecule within the DNA. WebSep 22, 2016 · Cytarabine is an effective drug in the treatment of certain hematologic malignancies and its common toxicities are myelosuppression and gastrointestinal disturbance. In the past decade, neurotoxicity has been an increasingly recognized cytarabine effect. Intrathecal (IT) cytarabine may result in myelopathy that is …
WebSep 21, 2024 · Patients with renal or hepatic impairment may be at increased risk of CNS toxicity associated with high-dose cytarabine therapy. Monitor patients receiving high-dose therapy closely for signs of central or peripheral neurotoxicity.
WebJul 6, 2024 · As with other anthracyclines, the use of this drug can cause myocardial toxicity leading to congestive heart failure. Cardiac toxicity is more common in patients who have received prior anthracyclines or who have preexisting cardiac disease. This drug can cause severe myelosuppression when it is used at effective therapeutic doses. inxs i\\u0027m only lookingWebCytarabine CLINICAL USE Antineoplastic agent:Acute leukaemias Lymphomatous meningitis DOSE IN NORMAL RENAL FUNCTION High-dose (infusional) therapy: 1–3 … onpolicy_trainerWebpatients with renal or hepatic function impairment may have a higher likelihood of CNS toxicity after high-dose cytarabine treatment. Use the drug with caution and possibly at reduced dose in patients whose liver or kidney function is poor. Periodic checks of bone marrow, liver and kidney functions should be performed in patients inxs it\\u0027s the one thingWebFeb 25, 2024 · Epidemiology of Anticancer Drug-Induced CLS. In cancer-treated patients, CLS is related to the cancer itself (43.6%), can occur after bone marrow transplantation (4.8%), but is mostly associated with anticancer agents (51.6%). 4 CLS is often a fatal complication of cytotoxic chemotherapy agents with an estimated mortality of 24% at 5 … on point xwordWebSep 4, 1991 · Cytarabine is an effective drug in the treatment of certain hematologic malignancies and its common toxicities are myelosuppression and gastrointestinal disturbance. In the past decade, neurotoxicity has been an increasingly recognized cytarabine effect. Intrathecal (IT) cytarabine may result in mye … Cytarabine and … onpoint worldwideWebNov 23, 2024 · Side effects include: IV, sub-Q, or IM administration of conventional cytarabine: Myelosuppression, anorexia, nausea, vomiting, diarrhea, oral and anal … inxs jan\u0027s song lyricsWebUse cytarabine with caution in patients with pre-existing drug-induced bone marrow suppression or impaired hepatic function. 2 Because of potential toxicity, do not use products containing benzyl alcohol or products reconstituted with preserved diluent intrathecally, for neonates, or for high-dose cytarabine regimens. 2 onpoint worldwide transportation